Nephronex Vitamin B-Complex Oral Liquid Recall
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Safecor Health, LLC is recalling 520 syringes of Nephronex Vitamin B-Complex, Vitamin C & Folic Acid Oral Liquid due to the presence of foreign black particles.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on June 10, 2026 and geographically references Ohio. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Drugs.
What Happened
Safecor Health, LLC initiated a voluntary recall due to the presence of a foreign substance, with black particles observed in the liquid.
Which Products Are Affected
Vitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid (Nephronex), NDC 54859-0516-08. Manufactured by LLORENS and packaged by Safecor Health, LLC in Columbus, OH. Affected lots: 26110722, 26110743 (exp 9/8/2026); 26111218 (exp 9/9/2026). Total of 520 syringes distributed in OH.
What You Should Do
Consumers should stop using the affected product.
Why This Matters
This Class II recall involves a drug product distributed in Ohio that may pose temporary or reversible adverse health consequences.
Source
FDA recall D-0549-2026
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (744 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to June 10, 2026.
Frequently Asked Questions
Common questions about this FDA recall.